Federico Pulido Ortega-rekin lankidetzan egindako argitalpenak (5)

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

2014

  1. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

2011

  1. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849

2005

  1. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804

2002

  1. Estudio epidemiológico retrospectivo sobre la duración del tratamiento de la infección por el virus de la inmunodeficiencia humana en España

    Medicina Clinica, Vol. 119, Núm. 19, pp. 721-724